Jiangxi Synergy Pharmaceutical Co., Ltd. (SHE:300636)

Market Cap	2.83B -7.0%
Revenue (ttm)	826.15M +11.7%
Net Income	71.09M -15.2%
EPS	0.17 -15.2%
Shares Out	419.95M
PE Ratio	39.89
Forward PE	33.75
Dividend	0.04 (0.60%)
Ex-Dividend Date	Jun 3, 2026

Volume	3,986,000
Open	6.70
Previous Close	6.75
Day's Range	6.56 - 6.77
52-Week Range	6.49 - 9.48
Beta	0.24
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHE:300636

Jiangxi Synergy Pharmaceutical Co., Ltd. engages in research and development, production, and sales of chemical raw materials and pharmaceutical intermediates in China and internationally. The company offers nervous system drugs, digestive system medications, antipyretic analgesics and non-steroidal anti-inflammatory analgesics, antihypertensive drugs, anticoagulants, hypoglycemic drugs, antidepressants, as well as antigout and urinary system medications. It also exports its products to Europe, the United States, Japan, South Korea, and other r...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2004
• Employees: 1,623
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300636

Financial Performance

In 2025, SHE:300636's revenue was 828.66 million, an increase of 9.19% compared to the previous year's 758.89 million. Earnings were 73.09 million, a decrease of -31.42%.